Evidence map›Paper›PMID 34091213›Full record

ArticleJournal of virological methods2021

SARS-CoV-2 detection by extraction-free qRT-PCR for massive and rapid COVID-19 diagnosis during a pandemic in Armenia.

Diana Avetyan, Andranik Chavushyan, Hovsep Ghazaryan, Ani Melkonyan, Ani Stepanyan, Roksana Zakharyan, Varduhi Hayrapetyan, Sofi Atshemyan, Gisane Khachatryan, Tamara Sirunyan and 8 more

Abstract read
In one paragraph

Article in Journal of virological methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Diana AvetyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia. Electronic address: d_avetyan@mb.sci.am.
Andranik ChavushyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
Hovsep GhazaryanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
Ani MelkonyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
Ani StepanyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
Roksana ZakharyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
Varduhi HayrapetyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
Sofi AtshemyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
Gisane KhachatryanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
Tamara SirunyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
Suren DavitavyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
Gevorg MartirosyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Davidyants Laboratories, Yerevan, 0054, Armenia.
Gayane Melik-AndreasyanNational Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
Shushan SargsyanNational Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
Armine GhazazyanNational Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
Naira AleksanyanNational Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
Xiushan YinApplied Biology Laboratory, Shenyang University of Chemical Technology, Shenyang, 110142, China; Biotech & Biomedicine Science (Shenyang)Co. Ltd, Shenyang, 110000, China.
Arsen ArakelyanLaboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 pandemic severely impacted the healthcare and economy on a global scale. It is widely recognized that mass testing is an efficient way to contain the spread of SARS-CoV-2 infection as well as aid in the development of informed policies for disease management. However, the current COVID-19 worldwide infection rates increased the demand for rapid and reliable screening of infection. We compared the performance of qRT-PCR in direct heat-inactivated (H), heat-inactivated and pelleted (HC) samples against RNA in a group of 74 subjects (44 positive and 30 negative). Then we compared the sensitivity of HC in a larger group of 196 COVID-19 positive samples. Our study suggests that HC samples show higher accuracy for SARS-CoV-2 detection PCR assay compared to direct H (89 % vs 83 % of the detection in RNA). The sensitivity of detection using direct samples varied depending on the sample transport and storage media as well as the viral loads (as measured by qRT-PCR Ct levels). Altogether, all the data suggest that purified RNA provides more accurate results, however, direct sample testing with qRT-PCR may help to significantly increase testing capacity. Switching to the direct sample testing is justified if the number of tests is doubled at least.

Indexed as

ArmeniaCOVID-19COVID-19 Nucleic Acid TestingHumansMass ScreeningReverse Transcriptase Polymerase Chain ReactionRNA, ViralSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingViral LoadVirus InactivationRNA, ViralCOVID-19Direct sample qRT-PCRHeat-InactivationPelletingSARS-CoV-2Virus detection

Identifiers

PMID34091213
PMCPMC8175123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.